Bruna Hoffmann de Oliveira

Dr. Bruna Hoffmann de Oliveira

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
AAAdriano Alberti
Adriano Alberti
DCDavid Richer Araujo Coelho
David Richer Araujo Coelho
Willians Fernando VieiraWillians Fernando Vieira
Willians Fernando Vieira
Betine Pinto Moehlecke IserBetine Pinto Moehlecke Iser
Betine Pinto Moehlecke Iser
RLRose Meiry Fernandez Lampert
Rose Meiry Fernandez Lampert
LALenita Agostinetto
Lenita Agostinetto
Depression affects several aspects of life, including socioeconomic status, relationships, behavior, emotions, and overall health. The etiology of depression is complex and influenced by various factors, with obesity emerging as a significant contributor. This narrative review aims to investigate the factors associated with the development of depression, with a particular focus on the role of obesity. The literature search was conducted on PubMed, Embase, and PsycINFO from May to July 2024. The review highlights the impact of environmental and socioeconomic conditions; lifestyle choices, including physical activity and dietary habits; stress; traumatic experiences; neurotransmitter imbalances; medical and psychological conditions; hormone fluctuations; and epigenetic factors on depression. A key emphasis is placed on the inflammatory processes linked to obesity, which may drive the bidirectional relationship between obesity and depression. The findings suggest that obesity is associated with an increased risk of depression, potentially due to chronic inflammation, neurochemical dysregulation, and the emotional and social challenges related to weight stigma and obesity management. Understanding these interconnected factors is important for developing targeted interventions to address both obesity and depression, leading to improved quality of life for those affected.

1 January 2026 in Molecular Neurobiology
Verified
Journal Article
Open access
PDF file
ELElisa Mitkus Flores Lins
Elisa Mitkus Flores Lins
ACAnelise Leal Vieira Cubas
Anelise Leal Vieira Cubas
BOBruna Hoffmann de Oliveira
Bruna Hoffmann de Oliveira
EMEduarda Behenck Medeiros
Eduarda Behenck Medeiros
KMKhiany Mathias
Khiany Mathias
FBFranciane Bobinski
Franciane Bobinski
Spent ground coffee oil (SGCO), rich in antioxidants and bioactive compounds, exhibits anti-inflammatory and analgesic properties and therefore warrants investigation in inflammatory pain models. This study aimed to investigate the topical effects of SGCO on hyperalgesia, emotional behavior, and inflammation-related mechanisms in a Complete Freund’s Adjuvant (CFA)-induced inflammation model. SGCO was extracted from spent coffee grounds via non-thermal plasma (NTP) and incorporated into a transdermal vehicle at 10%, 20%, and 30% (w/w). Female Balb/c mice (2 months old, n = 8/group) received daily topical applications of SGCO for 14 days after CFA-induced inflammation. Mechanical and cold nociception and paw edema were assessed. The concentration with the strongest antihyperalgesic effect (20%) was used in further experiments assessing mechanical conflict avoidance, anxiety- and depression-like behaviors, cytokine and oxidative parameters (paw, spinal cord, hippocampus, and prefrontal cortex), and inflammatory pathways in paw tissue. SGCO at 10%, 20%, and 30% produced significant antihyperalgesic effects without affecting paw edema, with 20% providing a sustained effect for 11 days. SGCO 20% was associated with reduced anxiety-like behavior, improved hedonic-like behavior without altering locomotion, and reduced pro-inflammatory cytokines (interleukin-1β and tumor necrosis factor), myeloperoxidase activity, phospho-Akt1/2/3, and NLRP3 in paw tissue. Additionally, it decreased protein carbonyl levels while increasing sulfhydryl group levels in the prefrontal cortex and hippocampus. These findings indicate that SGCO modulates inflammatory and oxidative pathways associated with CFA-induced inflammation and produces measurable effects on nociceptive and behavioral outcomes. Although the magnitude of the effects was generally modest, SGCO obtained via NTP technology may represent a low-cost and environmentally sustainable source of bioactive compounds for further preclinical investigation. Graphical Abstract